The seven-episode series unfolds along the misty banks of the Malaprabha River in rural North Karnataka, where fear moves quietly, and nothing is what it seems, reads the official logline of Rakshasa.

Proxy advisory firm InGovern called for a detailed audit of Zee Entertainment Enterprises’ related-party transactions and the appointment of a professional Managing Director, citing “a governance ...

Following the success of 'Dhurandhar', its makers are releasing the sequel in South Indian languages, with the Kannada teaser now out. Fans are buzzing about the March 19th clash with Yash's 'Toxic', ...

Aparna Ramachandran has shared on LinkedIn that she has joined Zee Entertainment Enterprises Limited as EVP and Head of Network Digital. Prior to this appointment, she was with Balaji Telefilms Ltd.

Zee Entertainment UK has launched its flagship Zee TV as a FAST Channel on Samsung TV Plus across Germany, Austria and Switzerland (DACH). German audiences can stream Zee TV’s latest dramas, reality ...

Kannada television audiences are in for a grand cinematic treat with the World Television Premiere of the much-anticipated historical action drama Kantara: A Legend – Chapter 1. The film will air ...

Zee Entertainment Enterprises' share price jumped as much as 4% in intraday trade on the BSE on Thursday, January 22, ahead of the company's December quarter earnings. Zee Entertainment's shares are ...

Priyanka Achar, who made a strong entry into Kannada cinema with Elumale, has signed her second feature film. The young actor first gained public attention by winning Zee Kannada’s reality show ...

Gilli Nata has been crowned the winner of Bigg Boss Kannada Season 12, taking home the trophy along with a cash prize of Rs 50 lakh after an intense grand finale. Gilli Nata celebrates after winning ...

Add Yahoo as a preferred source to see more of our stories on Google. Ginger Zee, ABC News' chief meteorologist, is putting all of her necessities (aside from her husband, Ben Aaron, and their two ...

SHANGHAI, Feb. 23, 2025 /PRNewswire/ -- BioCity Biopharma (BioCity) announced that its selective endothelin receptor type A (ET A) antagonist, SC0062, met the 12-week primary endpoint of a reduction ...